|
51 |
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Enthalten in Bone marrow transplantation Bd. 59, 13.4.2024, Nr. 7, date:7.2024: 1012-1021
|
|
|
|
52 |
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)
Enthalten in Annals of hematology Bd. 102, 10.7.2023, Nr. 9, date:9.2023: 2543-2553
|
|
|
|
53 |
Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party
Enthalten in Bone marrow transplantation Bd. 59, 4.6.2024, Nr. 9, date:9.2024: 1239-1246
|
|
|
|
54 |
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
Enthalten in Blood cancer journal Bd. 14, 15.3.2024, Nr. 1, date:12.2024: 1-8
|
|
|
|
55 |
Real world outcome analysis of treosulfan-based conditioning prior to allo-HCT in patients with MDS compared to clinical trial data
Enthalten in Bone marrow transplantation Bd. 60, 5.11.2024, Nr. 1, date:1.2025: 103-106
|
|
|
|
56 |
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome
Enthalten in Nature cancer Bd. 5, 13.5.2024, Nr. 8, date:8.2024: 1227-1249
|
|
|
|
57 |
The role of autologous stem cell transplantation (ASCT) in aggressive B-cell lymphomas: real-world data from a retrospective single-center analysis
Enthalten in Annals of hematology Bd. 100, 3.9.2021, Nr. 11, date:11.2021: 2733-2744
|
|
|
|
58 |
Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial
Enthalten in Bone marrow transplantation Bd. 57, 18.8.2022, Nr. 11, date:11.2022: 1664-1670
|
|
|
|
59 |
Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT
Enthalten in Blood cancer journal Bd. 9, 12.4.2019, Nr. 4, date:4.2019: 1-7
|
|
Administration
